Guillot C - Search Results

1

Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway.

Rouault JP, Falette N, Guéhenneux F, Guillot C, Rimokh R, Wang Q, Berthet C, Moyret-Lalle C, Savatier P, Pain B, Shaw P, Berger R, Samarut J, Magaud JP, Ozturk M, Samarut C, Puisieux A. Rouault JP, et al. Among authors: guillot c. Nat Genet. 1996 Dec;14(4):482-6. doi: 10.1038/ng1296-482. Nat Genet. 1996. PMID: 8944033

2

Alteration of p53 damage response by tamoxifen treatment.

Guillot C, Falette N, Courtois S, Voeltzel T, Garcia E, Ozturk M, Puisieux A. Guillot C, et al. Clin Cancer Res. 1996 Sep;2(9):1439-44. Clin Cancer Res. 1996. PMID: 9816318

3

p53-mediated cellular response to DNA damage in cells with replicative hepatitis B virus.

Puisieux A, Ji J, Guillot C, Legros Y, Soussi T, Isselbacher K, Ozturk M. Puisieux A, et al. Among authors: guillot c. Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1342-6. doi: 10.1073/pnas.92.5.1342. Proc Natl Acad Sci U S A. 1995. PMID: 7877979 Free PMC article.

4

p21(WAF1/CIP1) response to genotoxic agents in wild-type TP53 expressing breast primary tumours.

Guillot C, Falette N, Paperin MP, Courtois S, Gentil-Perret A, Treilleux I, Ozturk M, Puisieux A. Guillot C, et al. Oncogene. 1997 Jan 9;14(1):45-52. doi: 10.1038/sj.onc.1200803. Oncogene. 1997. PMID: 9010231

5

William L. McGuire Memorial Symposium. 1,25(OH)2D3 modulation of mammary tumor cell growth in vitro and in vivo.

Saez S, Falette N, Guillot C, Meggouh F, Lefebvre MF, Crepin M. Saez S, et al. Among authors: guillot c. Breast Cancer Res Treat. 1993;27(1-2):69-81. doi: 10.1007/BF00683194. Breast Cancer Res Treat. 1993. PMID: 8260731

6

Influence of tumor derived fibroblasts and 1,25-dihydroxyvitamin D3 on growth of breast cancer cell lines.

Lefebvre MF, Guillot C, Crepin M, Saez S. Lefebvre MF, et al. Among authors: guillot c. Breast Cancer Res Treat. 1995 Mar;33(3):189-97. doi: 10.1007/BF00665943. Breast Cancer Res Treat. 1995. PMID: 7749146

7

Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes.

Guillot C, Martel N, Berby F, Bordes I, Hantz O, Blanchet M, Sureau C, Vaillant A, Chemin I. Guillot C, et al. PLoS One. 2017 Jun 21;12(6):e0179697. doi: 10.1371/journal.pone.0179697. eCollection 2017. PLoS One. 2017. PMID: 28636622 Free PMC article.

8

PARP inhibition and the radiosensitizing effects of the PARP inhibitor ABT-888 in in vitro hepatocellular carcinoma models.

Guillot C, Favaudon V, Herceg Z, Sagne C, Sauvaigo S, Merle P, Hall J, Chemin I. Guillot C, et al. BMC Cancer. 2014 Aug 20;14:603. doi: 10.1186/1471-2407-14-603. BMC Cancer. 2014. PMID: 25139788 Free PMC article.

9

Update on hepatocellular carcinoma breakthroughs: poly(ADP-ribose) polymerase inhibitors as a promising therapeutic strategy.

Guillot C, Hall J, Herceg Z, Merle P, Chemin I. Guillot C, et al. Clin Res Hepatol Gastroenterol. 2014 Apr;38(2):137-42. doi: 10.1016/j.clinre.2013.07.006. Epub 2013 Aug 13. Clin Res Hepatol Gastroenterol. 2014. PMID: 23953496 Review.

10

Implementation of an in-house quantitative real-time polymerase chain reaction method for Hepatitis B virus quantification in West African countries.

Ghosh S, Sow A, Guillot C, Jeng A, Ndow G, Njie R, Toure S, Diop M, Mboup S, Kane CT, Lemoine M, Thursz M, Zoulim F, Mendy M, Chemin I. Ghosh S, et al. Among authors: guillot c. J Viral Hepat. 2016 Nov;23(11):897-904. doi: 10.1111/jvh.12561. Epub 2016 Jun 29. J Viral Hepat. 2016. PMID: 27353593

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters